These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Multiple early factors anticipate post-acute COVID-19 sequelae. Su Y; Yuan D; Chen DG; Ng RH; Wang K; Choi J; Li S; Hong S; Zhang R; Xie J; Kornilov SA; Scherler K; Pavlovitch-Bedzyk AJ; Dong S; Lausted C; Lee I; Fallen S; Dai CL; Baloni P; Smith B; Duvvuri VR; Anderson KG; Li J; Yang F; Duncombe CJ; McCulloch DJ; Rostomily C; Troisch P; Zhou J; Mackay S; DeGottardi Q; May DH; Taniguchi R; Gittelman RM; Klinger M; Snyder TM; Roper R; Wojciechowska G; Murray K; Edmark R; Evans S; Jones L; Zhou Y; Rowen L; Liu R; Chour W; Algren HA; Berrington WR; Wallick JA; Cochran RA; Micikas ME; ; Wrin T; Petropoulos CJ; Cole HR; Fischer TD; Wei W; Hoon DSB; Price ND; Subramanian N; Hill JA; Hadlock J; Magis AT; Ribas A; Lanier LL; Boyd SD; Bluestone JA; Chu H; Hood L; Gottardo R; Greenberg PD; Davis MM; Goldman JD; Heath JR Cell; 2022 Mar; 185(5):881-895.e20. PubMed ID: 35216672 [TBL] [Abstract][Full Text] [Related]
8. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae. LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735 [TBL] [Abstract][Full Text] [Related]
9. Tissue injury and leukocyte changes in post-acute sequelae of SARS-CoV-2: review of 2833 post-acute patient outcomes per immune dysregulation and microbial translocation in long COVID. Islam MS; Wang Z; Abdel-Mohsen M; Chen X; Montaner LJ J Leukoc Biol; 2023 Mar; 113(3):236-254. PubMed ID: 36807444 [TBL] [Abstract][Full Text] [Related]
10. Serological response to vaccination in post-acute sequelae of COVID. Joung S; Weber B; Wu M; Liu Y; Tang AB; Driver M; Sternbach S; Wynter T; Hoang A; Barajas D; Kao YH; Khuu B; Bravo M; Masoom H; Tran T; Sun N; Botting PG; Claggett BL; Prostko JC; Frias EC; Stewart JL; Robertson J; Kwan AC; Torossian M; Pedraza I; Sterling C; Goldzweig C; Oft J; Zabner R; Fert-Bober J; Ebinger JE; Sobhani K; Cheng S; Le CN BMC Infect Dis; 2023 Feb; 23(1):97. PubMed ID: 36797666 [TBL] [Abstract][Full Text] [Related]
11. Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword. Tan LY; Komarasamy TV; Rmt Balasubramaniam V Front Immunol; 2021; 12():742941. PubMed ID: 34659238 [TBL] [Abstract][Full Text] [Related]
12. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection. Moghimi N; Di Napoli M; Biller J; Siegler JE; Shekhar R; McCullough LD; Harkins MS; Hong E; Alaouieh DA; Mansueto G; Divani AA Curr Neurol Neurosci Rep; 2021 Jun; 21(9):44. PubMed ID: 34181102 [TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19. Gusev E; Sarapultsev A; Solomatina L; Chereshnev V Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163638 [TBL] [Abstract][Full Text] [Related]
15. Persistent serum protein signatures define an inflammatory subcategory of long COVID. Talla A; Vasaikar SV; Szeto GL; Lemos MP; Czartoski JL; MacMillan H; Moodie Z; Cohen KW; Fleming LB; Thomson Z; Okada L; Becker LA; Coffey EM; De Rosa SC; Newell EW; Skene PJ; Li X; Bumol TF; Juliana McElrath M; Torgerson TR Nat Commun; 2023 Jun; 14(1):3417. PubMed ID: 37296110 [TBL] [Abstract][Full Text] [Related]
16. Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseases. Herman JD; Atyeo C; Zur Y; Cook CE; Patel NJ; Vanni KM; Kowalski EN; Qian G; Srivatsan S; Shadick NA; Rao DA; Kellman B; Mann CJ; Lauffenburger D; Wallace ZS; Sparks JA; Alter G Sci Transl Med; 2023 Sep; 15(712):eadf6598. PubMed ID: 37672567 [TBL] [Abstract][Full Text] [Related]
17. The role of immune activation and antigen persistence in acute and long COVID. Opsteen S; Files JK; Fram T; Erdmann N J Investig Med; 2023 Jun; 71(5):545-562. PubMed ID: 36879504 [TBL] [Abstract][Full Text] [Related]
18. Epigenomics in COVID-19; the link between DNA methylation, histone modifications and SARS-CoV-2 infection. Shirvaliloo M Epigenomics; 2021 May; 13(10):745-750. PubMed ID: 33876664 [No Abstract] [Full Text] [Related]
19. Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Peluso MJ; Lu S; Tang AF; Durstenfeld MS; Ho HE; Goldberg SA; Forman CA; Munter SE; Hoh R; Tai V; Chenna A; Yee BC; Winslow JW; Petropoulos CJ; Greenhouse B; Hunt PW; Hsue PY; Martin JN; Daniel Kelly J; Glidden DV; Deeks SG; Henrich TJ J Infect Dis; 2021 Dec; 224(11):1839-1848. PubMed ID: 34677601 [TBL] [Abstract][Full Text] [Related]
20. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection. Patterson BK; Francisco EB; Yogendra R; Long E; Pise A; Rodrigues H; Hall E; Herrera M; Parikh P; Guevara-Coto J; Triche TJ; Scott P; Hekmati S; Maglinte D; Chang X; Mora-Rodríguez RA; Mora J Front Immunol; 2021; 12():746021. PubMed ID: 35082777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]